Clinical Trials Directory

Trials / Unknown

UnknownNCT03145051

Efficacy of Nasal Irrigation With Respimer® Netiflow® vs Saline Among Patients With Cystic Fibrosis and Chronic Rhinosinusitis

Prospective, Randomized, Cross-over, Multicenter, Trial Comparing the Efficacy and Tolerability of Nasal Irrigation With Respimer® Netiflow® Mineral Salts Solution Versus Saline Among Patients With Cystic Fibrosis and Suffering From Chronic Rhinosinusitis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Laboratoire de la Mer · Industry
Sex
All
Age
11 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Prospective, randomized, cross-over, multicenter, trial comparing the efficacy and tolerability of nasal irrigation with Respimer® mineral salts solution versus saline solution both administered with Respimer® Netiflow® medical device among patients aged ≥ 11 years and older with cystic fibrosis and suffering from chronic rhinosinusitis.

Conditions

Interventions

TypeNameDescription
OTHERSaline solutiona nasal irrigation care
OTHERRespimer Netiflowa nasal irrigation care

Timeline

Start date
2015-01-01
Primary completion
2017-10-01
Completion
2017-12-01
First posted
2017-05-09
Last updated
2017-09-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03145051. Inclusion in this directory is not an endorsement.